Mojibur Rohman Khan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mojibur Rohman Khan has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
Ashis K. Mukherjee
Division of Life Science, Institute of Advanced Study in Science and Technology, Paschim Boragaon, Guwahati 781035, Assam, India; Microbial Biotechnology and Protein Research Laboratory, Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur 784028, Assam, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, Uttar Pradesh, India
11 shared publications- Ashis Kumar Mukherjee
Institute of Advanced Study in Science & Technology
8 shared publications Atanu Adak
Molecular Biology and Microbial Biotechnology Laboratory, Institute of Advanced Study in Science and Technolgy, Vigyan Path, Paschim Boragaon, Guwahati, India
7 shared publicationsAnupam Bhattacharya
Institute of Advanced Study in Science and Technology
6 shared publicationsMaloyjo Joyraj Bhattacharjee
Division of Life Science, Institute of Advanced Study in Science and Technology, Paschim Boragaon, Guwahati 781035, Assam, India
6 shared publicationsSantanu Das
Life Sciences Division, Institute of Advanced Study in Science and Technology (IASST), Vigyan Path, Paschim Boragaon, Guwahati 35, Assam, India
6 shared publications
Latest Publications
- 30 October 2026
- Published by Wiley in Comprehensive Physiology
- Vol. 16 (6) , e70292
Gut Microbial Metabolites Mediated Immune Reprogramming in MASLD Spectrum: Mechanisms and Therapeutic Interventions
Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a leading cause of chronic liver disease driven by a complex interplay among microbes, metabolism, and inflammation. Emerging evidence positions the gut‐immune axis as a critical upstream driver of disease progression. Dysbiosis releases a mixture of injurious and protective metabolites, and the balance struck between them appears to determine whether immunity drives disease or restrains it. Acting on this balance, gut‐derived signals activate circulating and tissue‐resident immune cells, may impose trained immunity‐like states on myeloid progenitors, and can bias T and B cell differentiation toward pro‐inflammatory phenotypes. Chemokine‐driven recruitment then delivers these primed leukocytes to the steatotic liver, where we propose, as a hypothesis, that they act upon and amplify the responses of liver‐resident immune cells. Recent single‐cell, cohort, and genetic studies in patients are consistent with such an outside‐in sequence, although the number of studies is limited and they do not yet establish its direction. Therapeutically, microbiome‐based strategies aim to restore immune tolerance rather than suppress inflammation broadly. Targeting commensal‐derived short‐chain fatty acids, bile acid derivatives, tryptophan metabolites, and aryl hydrocarbon receptor ligands can reinforce regulatory networks by promoting regulatory T cells, IL‐10‐producing B cells, and tolerogenic myeloid states. We also outline emerging tools, including engineered microbes, targeted postbiotics, and microbial immune checkpoint modulation, which may offer opportunities to intercept MASLD at early and potentially reversible stages.
- 30 October 2026
- Published by Wiley in Comprehensive Physiology
- Vol. 16 (6) , e70292
Gut Microbial Metabolites Mediated Immune Reprogramming in MASLD Spectrum: Mechanisms and Therapeutic Interventions
Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a leading cause of chronic liver disease driven by a complex interplay among microbes, metabolism, and inflammation. Emerging evidence positions the gut‐immune axis as a critical upstream driver of disease progression. Dysbiosis releases a mixture of injurious and protective metabolites, and the balance struck between them appears to determine whether immunity drives disease or restrains it. Acting on this balance, gut‐derived signals activate circulating and tissue‐resident immune cells, may impose trained immunity‐like states on myeloid progenitors, and can bias T and B cell differentiation toward pro‐inflammatory phenotypes. Chemokine‐driven recruitment then delivers these primed leukocytes to the steatotic liver, where we propose, as a hypothesis, that they act upon and amplify the responses of liver‐resident immune cells. Recent single‐cell, cohort, and genetic studies in patients are consistent with such an outside‐in sequence, although the number of studies is limited and they do not yet establish its direction. Therapeutically, microbiome‐based strategies aim to restore immune tolerance rather than suppress inflammation broadly. Targeting commensal‐derived short‐chain fatty acids, bile acid derivatives, tryptophan metabolites, and aryl hydrocarbon receptor ligands can reinforce regulatory networks by promoting regulatory T cells, IL‐10‐producing B cells, and tolerogenic myeloid states. We also outline emerging tools, including engineered microbes, targeted postbiotics, and microbial immune checkpoint modulation, which may offer opportunities to intercept MASLD at early and potentially reversible stages.
- 29 June 2026
- Published by Springer Nature in Inflammopharmacology
- Vol. 34 (8) , 5281-5304
Bioactive compounds of Glycyrrhiza glabra and their functional role in modulating gut inflammation and intestinal homeostasis
This review critically examines the therapeutic potential of Glycyrrhiza glabra (licorice) and its bioactive compounds in supporting gastrointestinal health. The botanical profile, historical medicinal applications, and principal bioactive compounds, including glycyrrhizin, flavonoids, and polysaccharides, are described. Mechanistic insights reveal that G. glabra exerts multifaceted actions, including anti-inflammatory, antioxidant, immunomodulatory, barrier-enhancing, and microbiota-regulating effects, which contribute to the maintenance of intestinal homeostasis. An extensive evaluation of experimental and clinical studies demonstrates protective roles for G. glabra in disorders such as inflammatory bowel disease, gastritis, peptic ulcer disease, and irritable bowel syndrome. While clinical investigations and meta-analyses validate its symptom-alleviating properties and favorable safety profile at recommended dosages, potential adverse effects and contraindications warrant consideration. This review concludes by outlining current research gaps and highlighting future directions, emphasizing the need for rigorous clinical trials and mechanistic studies. Collectively, current evidence supports G. glabra as a promising phytopharmacological candidate for further investigation in the integrative management of gut inflammation, although additional clinical validation is required.
- 29 June 2026
- Published by Springer Nature in Inflammopharmacology
- Vol. 34 (8) , 5281-5304
Bioactive compounds of Glycyrrhiza glabra and their functional role in modulating gut inflammation and intestinal homeostasis
This review critically examines the therapeutic potential of Glycyrrhiza glabra (licorice) and its bioactive compounds in supporting gastrointestinal health. The botanical profile, historical medicinal applications, and principal bioactive compounds, including glycyrrhizin, flavonoids, and polysaccharides, are described. Mechanistic insights reveal that G. glabra exerts multifaceted actions, including anti-inflammatory, antioxidant, immunomodulatory, barrier-enhancing, and microbiota-regulating effects, which contribute to the maintenance of intestinal homeostasis. An extensive evaluation of experimental and clinical studies demonstrates protective roles for G. glabra in disorders such as inflammatory bowel disease, gastritis, peptic ulcer disease, and irritable bowel syndrome. While clinical investigations and meta-analyses validate its symptom-alleviating properties and favorable safety profile at recommended dosages, potential adverse effects and contraindications warrant consideration. This review concludes by outlining current research gaps and highlighting future directions, emphasizing the need for rigorous clinical trials and mechanistic studies. Collectively, current evidence supports G. glabra as a promising phytopharmacological candidate for further investigation in the integrative management of gut inflammation, although additional clinical validation is required.
- 3 December 2025
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 44 (12) , 1-23
Revealing the rationale behind the differential neutralization of phospholipase A 2 (PLA 2 ) enzymes in snake and bee venom by varespladib (LY-315920), a small molecule PLA 2 inhibitor
Phospholipase A2 (PLA2) enzyme found in snakes, bees, and wasps' venoms is responsible for toxicity and pathophysiology of envenomation. Varespladib (VP, LY-315920) is among the extensively researched small molecule inhibitors targeting snake venom (SV) PLA2 and PLA2-like proteins. Interestingly, it could not neutralize bee venom (BV) PLA2. To reveal this puzzle, we compared VP's in silico binding mechanisms with PLA2s from India's 'Big Four' snake venoms (BFSVs, Naja naja, Daboia russelii, Echis carinatus, and Bungarus caeruleus), nine viper venoms from four continents, and BV. VP binds SV-PLA2s in the same position but in a different position in the BV-PLA2s due to a clash between its phenyl ring and residues Tyr89 and Ile91, which might be the reason behind its universal activity against SV-PLA2s but negligible activity against BV-PLA2. Molecular docking and dynamics simulations identified optimal VP binding conformations with BFSV and BV-PLA2 proteins. In silico analysis results showed that the BFSV-PLA2-VP complex exhibited significantly greater binding affinity and stability than other PLA2-VP complexes, suggesting enhanced molecular interactions. The spectrofluorometric binding data showed a significantly higher binding affinity of VP with BFSV-PLA2s than BV-PLA2s, corroborated by differential inhibition of catalytic activity and anticoagulant activity of PLA2 enzymes from BV and SVs. VP showed significant neutralization of in vivo toxicity, generating reactive oxygen species and altering mitochondrial transmembrane potential induced by PLA2s from BFSV in the Caenorhabditis elegans model. However, such activities were not shown against BV-PLA2, indicating the limitations of broad-spectrum inhibitors like VP in neutralizing BV-PLA2.
- 3 December 2025
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 44 (12) , 1-23
Revealing the rationale behind the differential neutralization of phospholipase A 2 (PLA 2 ) enzymes in snake and bee venom by varespladib (LY-315920), a small molecule PLA 2 inhibitor
Phospholipase A2 (PLA2) enzyme found in snakes, bees, and wasps' venoms is responsible for toxicity and pathophysiology of envenomation. Varespladib (VP, LY-315920) is among the extensively researched small molecule inhibitors targeting snake venom (SV) PLA2 and PLA2-like proteins. Interestingly, it could not neutralize bee venom (BV) PLA2. To reveal this puzzle, we compared VP's in silico binding mechanisms with PLA2s from India's 'Big Four' snake venoms (BFSVs, Naja naja, Daboia russelii, Echis carinatus, and Bungarus caeruleus), nine viper venoms from four continents, and BV. VP binds SV-PLA2s in the same position but in a different position in the BV-PLA2s due to a clash between its phenyl ring and residues Tyr89 and Ile91, which might be the reason behind its universal activity against SV-PLA2s but negligible activity against BV-PLA2. Molecular docking and dynamics simulations identified optimal VP binding conformations with BFSV and BV-PLA2 proteins. In silico analysis results showed that the BFSV-PLA2-VP complex exhibited significantly greater binding affinity and stability than other PLA2-VP complexes, suggesting enhanced molecular interactions. The spectrofluorometric binding data showed a significantly higher binding affinity of VP with BFSV-PLA2s than BV-PLA2s, corroborated by differential inhibition of catalytic activity and anticoagulant activity of PLA2 enzymes from BV and SVs. VP showed significant neutralization of in vivo toxicity, generating reactive oxygen species and altering mitochondrial transmembrane potential induced by PLA2s from BFSV in the Caenorhabditis elegans model. However, such activities were not shown against BV-PLA2, indicating the limitations of broad-spectrum inhibitors like VP in neutralizing BV-PLA2.
- 31 August 2025
- Published by Elsevier in Process Biochemistry
- Vol. 158, 129-139
Statistical optimization of production and characterization of biosurfactant produced by Lactobacillus plantarum JBC5 strain in a ghee (clarified butter) medium: Assessment of its antimicrobial activity and stain removal property
- 31 August 2025
- Published by Elsevier in Process Biochemistry
- Vol. 158, 129-139
Statistical optimization of production and characterization of biosurfactant produced by Lactobacillus plantarum JBC5 strain in a ghee (clarified butter) medium: Assessment of its antimicrobial activity and stain removal property
- Open Access
- 28 July 2025
- Published by Taylor & Francis in Gut Microbes
- Vol. 17 (1) , 2537750
Interplay of miR-243 and microbial interactions in aging and transgenerational immunity
MicroRNAs (miRNAs) function in post-transcriptional regulation of gene expression and influence numerous biological processes. This commentary and view provide integrated insights from Kumar et al. (2024) and Gabaldon et al. (2020), emphasizing the role of miR-243 in promoting longevity and stress adaptation in response to microbial cues. However, further research is necessary to identify precise molecular targets of miR-243, comprehend its interactions with other miRNAs, validate its conservation in higher organisms, and to explore its potential toward targeted therapeutic strategies against aging and stress-related diseases.
- 28 July 2025
- Published by Taylor & Francis in Gut Microbes
- Vol. 17 (1) , 2537750
Open AccessInterplay of miR-243 and microbial interactions in aging and transgenerational immunity
MicroRNAs (miRNAs) function in post-transcriptional regulation of gene expression and influence numerous biological processes. This commentary and view provide integrated insights from Kumar et al. (2024) and Gabaldon et al. (2020), emphasizing the role of miR-243 in promoting longevity and stress adaptation in response to microbial cues. However, further research is necessary to identify precise molecular targets of miR-243, comprehend its interactions with other miRNAs, validate its conservation in higher organisms, and to explore its potential toward targeted therapeutic strategies against aging and stress-related diseases.
- Open Access
Lifestyle transition from rural to urban setting changes the gut bacterial profile in an ethnic community of northeast India
The human gut microbiome undergoes transformation due to various exogenous and endogenous influences. Lifestyle has been one of the major contributors of gut microbiome composition. Our study investigated the effect of migration on the gut microbiome of the Mishing ethnic community in India associated with urban migration from their pastural lifestyle. Gut bacterial diversity was profiled using 16S rRNA amplicon sequencing. We observed notable alterations in microbial diversity and composition, including changes in the core microbiome. While Bifidobacterium, Lactococcus and Streptococcus significantly increased (p < 0.01) among the migrant population there was depletion in bacteria such as Succinivibrio and Prevotella. This change in core microbiome was further reflected on the functional profile of the bacterial community harbored by the urban and rural dwellers. While the rural population was enriched in fatty acid biosynthesis pathways, amino acid and Vitamin B2 biosynthesis pathways were more prominent in the microbiome of the urban dwellers. We further observed increase in diversity and richness of the microbiome following migration. Co-analysis with ASVs from food samples consumed by the Mishing rural population revealed that 51 ASVs among the rural dwellers were from a widely consumed beverage, Apong which were completely absent among the migrants. Our analyses highlight the dietary preferences, particularly abstinence from specific foods and beverages, may modulate the alterations in gut microbial profiles. While the cross-sectional design and amplicon sequencing limited our ability to assess temporal and functional changes, our findings highlight a measurable impact of lifestyle and dietary transitions on the gut microbiome.
Open AccessLifestyle transition from rural to urban setting changes the gut bacterial profile in an ethnic community of northeast India
The human gut microbiome undergoes transformation due to various exogenous and endogenous influences. Lifestyle has been one of the major contributors of gut microbiome composition. Our study investigated the effect of migration on the gut microbiome of the Mishing ethnic community in India associated with urban migration from their pastural lifestyle. Gut bacterial diversity was profiled using 16S rRNA amplicon sequencing. We observed notable alterations in microbial diversity and composition, including changes in the core microbiome. While Bifidobacterium, Lactococcus and Streptococcus significantly increased (p < 0.01) among the migrant population there was depletion in bacteria such as Succinivibrio and Prevotella. This change in core microbiome was further reflected on the functional profile of the bacterial community harbored by the urban and rural dwellers. While the rural population was enriched in fatty acid biosynthesis pathways, amino acid and Vitamin B2 biosynthesis pathways were more prominent in the microbiome of the urban dwellers. We further observed increase in diversity and richness of the microbiome following migration. Co-analysis with ASVs from food samples consumed by the Mishing rural population revealed that 51 ASVs among the rural dwellers were from a widely consumed beverage, Apong which were completely absent among the migrants. Our analyses highlight the dietary preferences, particularly abstinence from specific foods and beverages, may modulate the alterations in gut microbial profiles. While the cross-sectional design and amplicon sequencing limited our ability to assess temporal and functional changes, our findings highlight a measurable impact of lifestyle and dietary transitions on the gut microbiome.